These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22855101)

  • 1. Optimizing 340B purchasing practices.
    Almeter PJ; Johnson GL; Saenz R
    Am J Health Syst Pharm; 2012 Aug; 69(16):1366-8, 1370-1. PubMed ID: 22855101
    [No Abstract]   [Full Text] [Related]  

  • 2. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 3. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
    [No Abstract]   [Full Text] [Related]  

  • 6. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: cost savings.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 9. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
    Lee J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Direct purchase of expensive medicine from the manufacturer may be required].
    Zimmermann GW
    MMW Fortschr Med; 2015 Jun; 157(11):12. PubMed ID: 26049324
    [No Abstract]   [Full Text] [Related]  

  • 11. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date.
    Health Resources and Services Administration, HHS
    Fed Regist; 2017 May; 82(96):22893-5. PubMed ID: 28574239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tips for preparing for a 340B integrity audit.
    Wood W; Jorgenson J; Kelly W
    Healthc Financ Manage; 2012 Dec; 66(12):50-2. PubMed ID: 23252228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 14. Manufacturer audit guidelines and dispute resolution process 0905-ZA-19--HRSA. Final notice.
    Fed Regist; 1996 Dec; 61(240):65406-13. PubMed ID: 10164014
    [No Abstract]   [Full Text] [Related]  

  • 15. HHS defends expanded 340B drug discounts.
    Lee J
    Mod Healthc; 2014 Jun; 44(24):9. PubMed ID: 25137989
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety nets still overpaying for drugs.
    Young D
    Am J Health Syst Pharm; 2006 Sep; 63(17):1584, 1586. PubMed ID: 16914624
    [No Abstract]   [Full Text] [Related]  

  • 17. Fast track to 340B.
    Gricius RF; Wong D
    Healthc Financ Manage; 2016 Jan; 70(1):56-62. PubMed ID: 26863836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry probe. Justice Department subpoenas dialysis providers.
    Mantone J
    Mod Healthc; 2004 Nov; 34(44):17. PubMed ID: 15554339
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal drug discount program proves tricky for hospitals to navigate.
    Thompson CA
    Am J Health Syst Pharm; 2000 Dec; 57(23):2130, 2134, 2139-40. PubMed ID: 11127690
    [No Abstract]   [Full Text] [Related]  

  • 20. Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's Proposal.
    Sachs RE; Bagley N
    N Engl J Med; 2020 May; 382(19):1777-1779. PubMed ID: 32374960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.